31 Results for "

lytic

" in MedChemExpress (MCE) Product Catalog:
Products (31)

31 Results for "lytic" in MCE Product Catalog:

Cat. No.: HY-N21571
CAS No.: 2113766-79-1
Euphominoid L is a diterpenoid EBV lytic replication inhibitor that can be found in the aerial parts of Euphorbia milii and shows oral activity. Euphominoid L suppresses EBV lytic replication. Euphominoid L can be used for the research of EBV virus infection .
loading...
    loading...
Cat. No.: HY-N21643
CAS No.: 2113766-67-7
Euphominoid A is a diterpenoid from Euphorbia milii and an EBV lytic replication inhibitor with low cytotoxicity against host cells. Euphominoid A inhibits EBV lytic replication in P3HR-1 cells. Euphominoid A can be used for the research of EBV infection .
loading...
    loading...
Cat. No.: HY-N9865
CAS No.: 155899-92-6
cis-Martynoside is a phenylpropanoid glycoside. Cis-Martynoside, in a mixture with trans-Martynoside, effectively inhibits the early activation of the lytic cycle of Epstein-Barr virus (EBV) and reduces the expression of Rta protein. cis-Martynoside can be used in research on EBV infection .
loading...
    loading...
Cat. No.: HY-P11784
CAS No.: 1423724-82-6
Target:  

Inhibitory Antibodies

Research Areas:  

Others

p5RHH is an acid-activated membrane-lytic peptide derived from melittin. p5RHH, as a siRNA delivery vector, initiates synchronous disassembly of nanocomplexes and endosome lysis in response to acidic pH, and triggers the release of siRNA into the cytoplasm following macropinocytosis .
loading...
    loading...
Cat. No.: HY-118598
CAS No.: 17511-50-1
Target:  

Autophagy

Research Areas:  

Cancer

UA8967 is a membrane-active antitumor agent. UA8967 exhibits enhanced cytotoxicity against cancer cells harboring a deletion of the tumor suppressor gene DPC4. By disrupting the integrity of the cytoplasmic membrane, UA8967 triggers early caspase-independent autophagy and ultimately leads to non-apoptotic cell lytic death. UA8967 can be used in research on colon cancer and pancreatic cancer .
loading...
    loading...
Cat. No.: HY-P706198
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: lytic switch protein BZLF1; EB1; Protein Z; Trans-activator protein BZLF1; Zta 1; bZIP transcription factor ZEBRA; BZLF1
Species:  
Virus
Source:  
E. coli
loading...
    loading...
Cat. No.: HY-183552
CAS No.: 1351572-56-9
mCPX is a prodrug of the antifungal agent Ciclopirox olamine (CPX) (HY-B0450A). CPX exhibits bacteriostatic and iron-chelating activities, while mCPX enhances the iron stability of CPX. mCPX inherits the core mechanism pathway of CPX and can induce EBV lytic reactivation in EBV + gastric cancer cells via the hypoxia pathway (HIF‑1α). mCPX is applicable to research related to EBV-positive gastric cancer .
loading...
    loading...
Cat. No.: HY-W277805
CAS No.: 549-68-8
Octaverine is a synthetic isoquinoline alkaloid with oral activity and adrenergic lytic activity. Octaverine antagonizes the pressor effect of adrenaline, elevates the toxicity threshold of adrenaline, and reduces blood pressure. Octaverine increases respiratory depth, respiratory frequency, ventilation rate, and coronary blood flow. Octaverine inhibits spontaneous uterine contractions, antagonizes induced intestinal spasms, alleviates histamine-induced bronchospasm, and exhibits favorable biosafety. Octaverine can be used in research related to intestinal spasms and bronchospasm .
loading...
    loading...
Cat. No.: HY-W989139
CAS No.: 178970-88-2
Target:  

Apoptosis

Research Areas:  

Inflammation/Immunology Cancer

Perforin-IN-3 is a specific perforin inhibitor that blocks perforin-mediated lytic pore formation and subsequent cell lysis. Perforin-IN-3 potently inhibits the killing effect of NK cells on target cells such as leukemia cells, without interfering with FasL- or TRAIL-mediated cell death pathways. Perforin-IN-3 has no effect on pneumolysin and can be used to study autoimmune diseases, allograft rejection, graft-versus-host disease, and familial hemophagocytic lymphohistiocytosis .
loading...
    loading...
Cat. No.: HY-P11820
Target:  

Bacterial

Research Areas:  

Infection

d-WRL is a cationic antimicrobial peptide with properties such as salt resistance, protease resistance and no induction of drug resistance. As a membrane lytic agent, d-WRL effectively kills planktonic MRSA, mature MRSA biofilms and Pseudomonas aeruginosa. d-WRL selectively interacts with negatively charged bacterial membranes, causing changes in membrane permeability, structural disintegration and leakage of intracellular substances, thereby precisely lysing bacteria without damaging zwitterionic mammalian cell membranes. d-WRL inhibits and eliminates mature MRSA biofilms, and can be used in studies of methicillin-resistant Staphylococcus aureus (MRSA) infections .
loading...
    loading...
Cat. No.: HY-L162
3,860 compounds

Cell death plays a crucial role in the development of the body and the maintenance of internal balance to prevent the development of diseases. According to the regulation of the involved processes, cell death can be defined as programmed and non-programmed death. Programmed cell death (PCD) can be divided into lytic cell death and nonlytic cell death, mainly including apoptosis, necrotic apoptosis and Pyroptosis. Non-Programmed cell death (Non-PCD) generally refers to necrosis. In stark contrast to Accidental Cell Death (ACD), Regulatory Cell Death (RCD) relies on specialized molecular mechanisms. Cell death includes internal apoptosis, external apoptosis, necrotic apoptosis, ferroptosis, pyroptosis, lysosome-dependent cell death, etc.

MCE designs a unique collection of 3,860 cell death compounds, covering multiple targets, such as Apoptosis, Ferroptosis, Pyroptosis, Necroptosis, etc. It is a useful tool for screening cell death drugs.